BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31658349)

  • 1. Neurofibromatosis type 1 associated with moyamoya syndrome. Case report and review of the literature.
    Budişteanu M; Burloiu CM; Papuc SM; Focşa IO; Riga D; Riga S; Arghir A
    Rom J Morphol Embryol; 2019; 60(2):713-716. PubMed ID: 31658349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis type 1 association with moyamoya disease.
    Koc F; Yerdelen D; Koc Z
    Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
    Han C; Yang WZ; Zhang HT; Ye T; Duan L
    J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moyamoya syndrome and neurofibromatosis type 1.
    Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
    Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.
    Serafini NB; Serafini CB; Vinhas AS; Godinho MB
    An Bras Dermatol; 2017; 92(6):870-873. PubMed ID: 29364453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
    Rosser TL; Vezina G; Packer RJ
    Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovasculopathy in NF1 associated with ocular and scalp defects.
    Smith M; Heran MK; Connolly MB; Heran HK; Friedman JM; Jett K; Lyons CJ; Steinbok P; Armstrong L
    Am J Med Genet A; 2011 Feb; 155A(2):380-5. PubMed ID: 21271658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moyamoya syndrome after radiation therapy for optic pathway glioma: case report.
    Serdaroğlu A; Simşek F; Gücüyener K; Oğuz A; Karadeniz C; Balibey M
    J Child Neurol; 2000 Nov; 15(11):765-7. PubMed ID: 11108514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1.
    Ullrich NJ; Zimmerman M; Smith E; Irons M; Marcus K; Kieran MW
    J Child Neurol; 2011 Feb; 26(2):228-30. PubMed ID: 20823033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
    Tan RM; Chng SM; Seow WT; Wong J; Lim CC
    Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report.
    Arita H; Narita Y; Ohno M; Miyakita Y; Okita Y; Ide T; Shibui S
    Childs Nerv Syst; 2013 Feb; 29(2):341-5. PubMed ID: 23108917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-Onset Hemorrhagic Quasi-Moyamoya Disease with Unilateral Steno-occlusive Lesion in a Patient with Neurofibromatosis Type 1.
    Hori YS; Ebisudani Y; Aoi M; Fukuhara T
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1423-1424. PubMed ID: 29305273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
    Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
    Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient.
    Darrigo Júnior LG; Valera ET; Machado Ade A; Santos AC; Scrideli CA; Tone LG
    Sao Paulo Med J; 2011 Mar; 129(2):110-2. PubMed ID: 21603789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pediatric case of NF1 and moyamoya syndrome: Neuropsychological evaluation pre- and post-EDAS.
    DeDios-Stern S; Ventura LM
    Appl Neuropsychol Child; 2021; 10(3):283-296. PubMed ID: 31523973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya syndrome related to neurofibromatosis of type 1: a case report.
    Delvoye F; Hervé D; Chabriat H; Mawet J
    Acta Neurol Belg; 2013 Dec; 113(4):539-41. PubMed ID: 24085541
    [No Abstract]   [Full Text] [Related]  

  • 18. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
    Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
    Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epilepsy surgery for a patient with neurofibromatosis type 1 concomitant with moyamoya syndrome.
    Kuroda N; Fujimoto A; Okanishi T; Sato K; Nishimura M; Enoki H
    J Clin Neurosci; 2019 Mar; 61():307-310. PubMed ID: 30381160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scoliosis Secondary to Neurofibromatosis Type I Combined With Moyamoya Syndrome: A Case Report.
    Zhang H; Luo Y; Guo D; Yao Z; Liu H; Zhang X
    JBJS Case Connect; 2022 Jul; 12(3):. PubMed ID: 36137072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.